Free Trial
NYSEARCA:IPO

Renaissance IPO ETF (IPO) Price, Holdings, & News

Renaissance IPO ETF logo
$50.36 +0.59 (+1.19%)
As of 11:20 AM Eastern

About Renaissance IPO ETF (NYSEARCA:IPO)

Advanced

Key Stats

Today's Range
$49.48
$50.36
50-Day Range
$39.67
$52.29
52-Week Range
$39.31
$54.68
Volume
10,294 shs
Average Volume
27,446 shs
Market Capitalization
$146.04 million
Assets Under Management
$141.76 million
Dividend Yield
0.52%
Net Expense Ratio
0.60%
Aggregate Rating
Moderate Buy

ETF Overview

Renaissance IPO ETF Expenses

TypeIPOTheme ETFsEquity ETFsNYSEARCA ETFsAll ETFs
Management Fee0.60%0.57%0.57%0.51%0.53%
Other Expenses0.00%0.57%0.55%0.58%0.55%
Total Expense0.60%0.73%0.76%0.74%0.73%
Fee Waiver0.00%-0.74%-0.64%-0.70%-0.61%
Net Expense0.60%0.60%0.63%0.58%0.60%
Receive IPO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Renaissance IPO ETF and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

IPO ETF News Headlines

Microscopic Footage Shows Immune Cells Attacking Cancer
Early human trial data from one NASDAQ-listed biotech showed up to a 63.7% reduction in cancer burden using its TriKE platform, which is designed to keep Natural Killer cells active and targeted longer than standard approaches. The company's next-generation version shows potential for 10-40x greater potency and has already cleared an important FDA milestone. Watch the microscopic footage and see what the next catalyst could mean for investors.tc pixel
See More Headlines

IPO ETF - Frequently Asked Questions

Renaissance IPO ETF's stock was trading at $45.65 at the beginning of the year. Since then, IPO shares have increased by 9.2% and is now trading at $49.83.

Top institutional shareholders of Renaissance IPO ETF include Cetera Investment Advisers (2.48%), Kestra Private Wealth Services LLC (0.44%), Wealthfront Advisers LLC (0.22%) and NFSG Corp (0.03%).

Shares of IPO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Renaissance IPO ETF investors own include NVIDIA (NVDA), Walt Disney (DIS), Meta Platforms (META), Advanced Micro Devices (AMD), Qualcomm (QCOM), Alibaba Group (BABA) and

Fund Details

Issuer
Renaissance Capital
Fund Name
Renaissance IPO ETF
Tax Classification
Regulated Investment Company
Stock Exchange
NYSEARCA
Current Symbol
NYSEARCA:IPO
Inception Date
10/14/2013
Fund Manager
Linda R. Killian, William K. Smith
Web
N/A
Phone
N/A

Fund Focus

Asset Class
Equity
Benchmark
Renaissance IPO Index
Category
Strategy
Focus
Theme
Development Level
Developed Markets
Region
North America
Number of Holdings
49

Fund Statistics

Assets Under Management
$141.76 million
Average Daily Volume
$23.16 thousand
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
State Street Bank and Trust Company
Advisor
Renaissance Capital, LLC
Custodian
State Street Bank and Trust Company
Distributor
Foreside Fund Services, LLC
Transfer Agent
State Street Bank and Trust Company
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
10
Put Options
1
Call Options
9
Short Interest
194,100 shs

Miscellaneous

Beta
1.32
Creation Unit
50,000
Creation Fee
$500.00
10 Best Stocks to Own in 2026 Cover

Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Spring 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

Top 10 IPO Holdings

IPO Sector Exposure

IPO Industry Exposure


This page (NYSEARCA:IPO) was last updated on 5/14/2026 by MarketBeat.com Staff.
From Our Partners